Impact Study of Cholera Vaccination in Endemic Areas - Clinical Surveillance
ConditionCholera
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
AgeNot listed
SponsorEpicentre
About this trial
This project aims to fill this essential knowledge gap by assessing the impact of oral cholera vaccine mass campaigns in 2 sites (urban and rural) in DRC, described in this protocol. The evidence generated from this project will be key to develop future strategies regarding cholera vaccine use in endemic settings, including places with higher burden in terms of cholera mortality.
Eligibility criteria
Qualifiers
All patients presenting at the time of the study to any selected Cholera Treatment Center/Cholera Treatment Unit (CTC/CTU), matching the case definition and giving his/her consent (or assent for children 8 to 17 years old) to participate in the study will be eligible.
Disqualifiers
Patients who decline to participate will be excluded from the study.
present to any selected CTC/CTU, match the case definition, participate to the clinical surveillance activity and test positive to RDT OR
Be a household member of a person respecting inclusion criteria 1. AND for whom the head of the household has provided verbal consent to participate AND giving his/her consent (or assent for children 8 to 17 years old) to participate in the study will be eligible.
Trial design
Treatments tested in this trial
- Not listed
Trial groups
No trial groups listed
Sponsors and collaborators
Epicentre
Lead sponsor
Wellcome Trust
Collaborator
Médecins Sans Frontières, France
Collaborator
Ministry of Public Health, Democratic Republic of the Congo
Collaborator
Institut National de Recherche Biomédicale. Goma, République Démocratique du Congo
Collaborator
Grand Labo de Lubumbashi
Collaborator
Source ClinicalTrials.gov